Assignee
CELLZOME AG
DE·2 granted patents·9 pending applications·6 citations·filing 2003–2010
Top patents by PatentIndex Score
11 records- 0173US8349861B2Methods for identification of JAK kinase interacting molecules and for the purification of JAK kinasesCELLZOME AG·Filed 2008·Granted Jan 8, 2013·6 cites·21 claims
- 0245US2005288212A1Components of the presenilin-complexCELLZOME AG·Filed 2003·Application pending·0 cites
- 0344US2008176803A1Components of the presenilin-complexCELLZOME AG·Filed 2008·Application pending·0 cites
- 0444US2011070595A1Methods for the identification of parp interacting molecules and for purification of parp proteinsCELLZOME AG·Filed 2009·Application pending·0 cites
- 0543US2007161554A1Treatment of neurodegenerative diseases by the use of laptm4bCELLZOME AG·Filed 2004·Application pending·0 cites
- 0642US2011111972A1Selectivity profiling of pi3k interacting molecules against multiple targetsCELLZOME AG·Filed 2009·Application pending·0 cites
- 0742US2006264610A1Protein complexes of the tip60 transcriptional activator proteinCELLZOME AG·Filed 2003·Application pending·0 cites
- 0841US8367830B2Methods for the identification of phosphatidylinositol kinase interacting molecules and for the purification of phosphatidylinositol kinase proteinsCELLZOME AG·Filed 2010·Granted Feb 5, 2013·0 cites·14 claims
- 0939US2006216292A1Treatment of neurodegenerative diseasesCELLZOME AG·Filed 2004·Application pending·0 cites
- 1038US2007280927A1Treatment Of Neurodegenerative Diseases By The Use Of Atp7aCELLZOME AG·Filed 2004·Application pending·0 cites
- 1134US2008038249A1Treatment Of Neurodegenerative Diseases By The Use Of Laptm4aCELLZOME AG·Filed 2005·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →